Massachusetts Financial Services CO Phathom Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

  • $321 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$33.22 - $50.26 $556,601 - $842,106
-16,755 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$29.24 - $40.19 $19,210 - $26,404
-657 Reduced 3.77%
16,755 $614,000
Q2 2020

Aug 11, 2020
BUY
$25.06 - $54.6 $436,344 - $950,695
17,412 New
17,412 $573,000

Others Institutions Holding PHAT

# of Institutions
123
Shares Held
54.7M
Call Options Held
34K
Put Options Held
58.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $409M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email